Alliance Entertainment Reports First Quarter Fiscal Year 2026 Results GlobeNewswire November 12, 2025 Revenue up 11% to $254M, driven by strength in physical media and collectibles Adjusted EBITDA up 259% to $12.2M; Gross Margin expands 340 basis points to 14.6% Net Income increased to $4.9M, or $0.10 per share, compared to $0.4M in Q1 FY25 […]
Cellebrite Announces Third-Quarter 2025 Results GlobeNewswire November 12, 2025 ARR grew 19% to $439.8 million; Revenue grew 18% to $126.0 million Net income of $20.2 million supports non-GAAP net income of $36.9 million and adjusted EBITDA of $37.7 million, 29.9% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE)
Erasca Reports Third Quarter 2025 Business Updates and Financial Results GlobeNewswire November 12, 2025 U.S. composition of matter patent protection through 2043 for potential best-in-class pan-RAS molecular glue ERAS-0015 Strengthened scientific leadership with promotion of Robert Shoemaker, Ph.D., to chief scientific officer Initial Phase 1 monotherapy data for ERAS-0015 and pan-KRAS inhibitor ERAS-4001 expected in
Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London GlobeNewswire November 12, 2025 LONDON, Nov. 12, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 2:30 p.m. Greenwich Mean Time (9:30 a.m.
Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 GlobeNewswire November 12, 2025 Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025 Q3 revenues increased by 18% to $27.4 millionAdjusted EBITDA profitability of $1.0 million for Q3Acquisition of ExoDx business from Bio-Techne CorporationConference call with
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors GlobeNewswire November 12, 2025 GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions (NYSE: EBS) announced today that Dr. Louis W. Sullivan will retire from the company's Board of Directors effective November 14 after 19 years of service to the company
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights GlobeNewswire November 12, 2025 Third quarter 2025 net revenues were $17.6 million Emrosi(TM) total prescriptions increased 146% over the second quarter of 2025 Emrosi net revenues were $4.9 million Company to hold conference call today at 4:30 p.m. ET to discuss the
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update GlobeNewswire November 12, 2025 Strengthened cash position and extended runway into the fourth quarter of fiscal year 2027 after closing underwritten public offering with up to potentially $100 million of total gross proceeds Presented non-human primate data for our potentially first-in-class Activin E
Chesapeake Utilities Corporation (NYSE: CPK) has been recognized as Employer Champion of the Year for Kent County by the Delaware Department of Labor's Division of Vocational Rehabilitation and State Rehabilitation Council. This recognition celebrates employers who go above and beyond to promote accessibility and inclusion in the workplace and to help build equitable environments where
A 30-year-plus industry veteran, Purvey will spearhead strategic initiatives to fuel the company's long-term growth and drive revenue generation. Douglas Elliman Realty, LLC (“Douglas Elliman”), one of the largest residential real estate brokerages in the country with the highest national average sales price, announced today that it has appointed Wendy S. Purvey to the role